Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Yvonne, Huber"'
Autor:
Maurice Michel, Christian Labenz, Malena Anders, Alisha Wahl, Lisann Girolstein, Leonard Kaps, Wolfgang M. Kremer, Yvonne Huber, Peter R. Galle, Martin Sprinzl, Jörn M. Schattenberg
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 2011-2021 (2022)
Abstract Hepatic steatosis (HS) related to nonalcoholic fatty liver disease (NAFLD) is increasing globally. In people living with human immunodeficiency virus (PLWH) risk factors of HS are increased. The impact of HS on outcomes and in particular hea
Externí odkaz:
https://doaj.org/article/abd4c70e3c16460b838335e05984d99c
Autor:
Yvonne Huber, Andreas Schulz, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Peter R. Galle, Philipp S. Wild, Karl J. Lackner, Jörn M. Schattenberg
Publikováno v:
Hepatology Communications, Vol 6, Iss 6, Pp 1457-1466 (2022)
The prevalence of liver disease, and especially of advanced liver fibrosis, in the German population is poorly defined. The aim of the study was to explore liver enzymes and surrogate scores of hepatic steatosis and advanced hepatic fibrosis in a pop
Externí odkaz:
https://doaj.org/article/dbd731166b804f9fbc864e535e2a9119
Autor:
Christian Labenz, Yvonne Huber, Maurice Michel, Michael Nagel, Peter R. Galle, Karel Kostev, Jörn M. Schattenberg
Publikováno v:
Hepatology Communications, Vol 4, Iss 9, Pp 1293-1301 (2020)
Nonalcoholic fatty liver disease (NAFLD), depression, and anxiety disorders are frequent diseases, and data on mutual influence are inconsistent. The aim of this study was to explore the incidence of depression and anxiety in a large primary care coh
Externí odkaz:
https://doaj.org/article/2785d339da054f4e8e9619fe1d8ae9a6
Autor:
Felix Thol, Simon Johannes Gairing, Carolin Czauderna, Thomas Thomaidis, Thomas Gamstätter, Yvonne Huber, Johanna Vollmar, Johanna Lorenz, Maurice Michel, Fabian Bartsch, Lukas Müller, Roman Kloeckner, Peter Robert Galle, Marcus-Alexander Wörns, Jens Uwe Marquardt, Markus Moehler, Arndt Weinmann, Friedrich Foerster
Publikováno v:
JHEP Reports, Vol 4, Iss 3, Pp 100417- (2022)
Background & Aims: Advanced biliary tract cancer (ABTC) is associated with a poor prognosis. Real-world data on the outcome of patients with ABTC undergoing sequential chemotherapies remain scarce, and little is known about treatment options beyond t
Externí odkaz:
https://doaj.org/article/ca54cc67fe5d403f87475984aa7900e7
Autor:
Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate K. Straub, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg
Publikováno v:
Hepatology Communications, Vol 3, Iss 11, Pp 1472-1481 (2019)
Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low‐density lipoprotein c
Externí odkaz:
https://doaj.org/article/ae2db2b1d73742fbb742da7dfb63865a
Autor:
Yvonne Huber, Franziska Bierling, Christian Labenz, Sandra Koch, Irene Schmidtmann, Roman Kloeckner, Sebastian Schotten, Tobias Huber, Hauke Lang, Marcus A. Woerns, Peter R. Galle, Arndt Weinmann, Julia Weinmann-Menke
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background In hepatocellular carcinoma (HCC), the third leading cause of cancer-related mortality worldwide, the Child-Turcotte-Pugh score (CTP) is one of the most established tools to assess hepatic reserve and determine survival. Serum lev
Externí odkaz:
https://doaj.org/article/0cd5c267bb0b4fec9b101a587d030e96
Autor:
Maurice Michel, Christian Labenz, Alisha Wahl, Malena Anders, Angelo Armandi, Yvonne Huber, Peter R. Galle, Martin Sprinzl, Jörn M. Schattenberg
Publikováno v:
AIDS. 36:1665-1674
Metabolic risk factors and nonalcoholic fatty liver disease (NAFLD) in people with HIV (PWH) have been increasing. Patients exhibiting the inflammatory subtype nonalcoholic steatohepatitis (NASH) are at increased risk of liver-related complications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048ee011d541d9f90449ed10acdea5d9
https://doi.org/10.1097/qad.0000000000003312
https://doi.org/10.1097/qad.0000000000003312
Autor:
Katharina John, Martin Franck, SherinAl Aoua, Monika Rau, Yvonne Huber, Jörn Schattenberg, Andreas Geier, Matthias Bahr, Heiner Wedemeyer, Klaus Schulze-Osthoff, Heike Bantel
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0b2526304ccccba240f3aed0ea46b3e
https://doi.org/10.1055/s-0042-1759968
https://doi.org/10.1055/s-0042-1759968
Autor:
Michael Nagel, Marcus-Alexander Wörns, Yvonne Huber, A Grambihler, Francesca Spinelli, Jörn M. Schattenberg, Peter R. Galle, Maurice Michel, Leonard Kaps, Christian Labenz
Publikováno v:
Quality of Life Research
Background Autoimmune hepatitis (AIH) is a rare chronic liver disease. Impaired health-related quality of life (HRQL) contributes to the overall disease burden. At current, only limited data related to the impact of treatment response on HRQL are ava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15cb7a41da8a82a7a047363be5654ad
http://europepmc.org/articles/PMC8481193
http://europepmc.org/articles/PMC8481193
Autor:
Yvonne Huber, Jens U. Marquardt, M Hilscher, Gerrit Toenges, Robert Kuchen, Peter R. Galle, Christian Labenz, Michael Nagel, Jörn M. Schattenberg, Joachim Labenz, Marcus-Alexander Wörns
Publikováno v:
European Journal of Internal Medicine. 82:83-89
Non-selective β-blockers (NSBB) are frequently used for the treatment of portal hypertension and gastroesophageal varices in patients with liver cirrhosis; however prospective studies investigating the potential association between NSBB use and hepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39e7ec0fc25e9d5b3e1f56bdb37f293
https://doi.org/10.1016/j.ejim.2020.08.022
https://doi.org/10.1016/j.ejim.2020.08.022